1.Unahon tool: The development of a mental health triage tool for evacuation centers in the Philippines.
Anna Cristina A. TUAZON ; Carlos Primero D. GUNDRAN ; Hilton Y. LAM ; Jerome Visperas CLEOFAS ; Fernando B. GARCIA JR. ; Rene Ela P. IGNACIO ; Danielle Marie A. PARREÑO ; Yra Marie CALAMIONG-OTCHENGCO ; Maria Carmina L. YATCO
Acta Medica Philippina 2025;59(14):23-36
		                        		
		                        			
		                        			BACKGROUND<p style="text-align: justify;" data-mce-style="text-align: justify;">The Philippines faces a challenge in addressing the mental health needs of internally displaced persons (IDPs) following disasters. The lack of an integrated mental health triage system within evacuation centers and the shortage of specialists trained in post-traumatic stress triaging have hindered effective emergency response. Existing interventions primarily focus on traditional trauma and psychiatric symptoms, often lacking standardized mental health triage classifications and leading to data gaps, complicating resource allocation decisions.p>OBJECTIVE<p style="text-align: justify;" data-mce-style="text-align: justify;">To develop a culturally relevant mental health triage system, this study proposes the "Unahon Tool" to meet the needs of Filipino IDPs. Integrating with existing medical triage protocols equips frontline responders to identify stress-related concerns, enables informed decision-making for mental health and psychosocial support (MHPSS) allocation, and optimizes resource utilization.p>METHODS<p style="text-align: justify;" data-mce-style="text-align: justify;">The study involved key informants, including disaster responders, mental health specialists, and government officials, who participated in interviews and focus group discussions. Thematic analysis was used to identify behavioral aspects affecting IDP communities. The Unahon Tool development incorporated disaster response frameworks, mental health interventions, and other existing triage tools. A red-yellow-green categorization system was employed based on the severity and urgency of observed behaviors. Stakeholder consultations and expert reviews guided tool refinement.p>RESULTS<p style="text-align: justify;" data-mce-style="text-align: justify;">The final Unahon Tool includes 17 behaviors categorized into red (urgent), yellow (moderate), and green (low) severity levels. It provides corresponding recommended interventions to aid responders. During direct observations, yellow-category behaviors like shouting and cursing were prevalent. Responders focused on reminders for peace and order in response to these behaviors. The tool's "Notes" section was identified as a potential area for contextual information inclusion.p>CONCLUSION<p style="text-align: justify;" data-mce-style="text-align: justify;">The Unahon Tool fills a crucial gap in the Philippine disaster response infrastructure by offering a behavior-based mental health triage system. It enables responders to prioritize mental health resources effectively, reducing the burden on specialists and enhancing overall disaster response effectiveness. Future directions   include expanding tool adoption beyond Metro Manila, translating it into regional languages, and developing a version for children and teenagers. Collaboration with other regions and age groups will ensure broader applicability and effectiveness in addressing mental health needs among diverse IDP populations.p>
		                        		
		                        		
		                        		
		                        			Human
		                        			;
		                        		
		                        			Mental Health
		                        			;
		                        		
		                        			Disasters
		                        			;
		                        		
		                        			Philippines
		                        			
		                        		
		                        	
2.Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development.
Carlos R OLIVEIRA ; Daniel G SPINDOLA ; Daniel M GARCIA ; Adolfo ERUSTES ; Alexandre BECHARA ; Caroline PALMEIRA-DOS-SANTOS ; Soraya S SMAILI ; Gustavo J S PEREIRA ; André HINSBERGER ; Ezequiel P VIRIATO ; Maria CRISTINA MARCUCCI ; Alexandra C H F SAWAYA ; Samantha L TOMAZ ; Elaine G RODRIGUES ; Claudia BINCOLETTO
Journal of Integrative Medicine 2019;17(2):132-140
		                        		
		                        			OBJECTIVE:
		                        			Although Angelica archangelica is a medicinal and aromatic plant with a long history of use for both medicinal and food purposes, there are no studies regarding the antineoplastic activity of its root. This study aimed to evaluate the cytotoxicity and antitumor effects of the crude extract of A. archangelica root (CEAA) on breast cancer.
		                        		
		                        			METHODS:
		                        			The cytotoxicity of CEAA against breast adenocarcinoma cells (4T1 and MCF-7) was evaluated by a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Morphological and biochemical changes were detected by Hoechst 33342/propidium iodide (PI) and annexin V/PI staining. Cytosolic calcium mobilization was evaluated in cells staining with FURA-4NW. Immunoblotting was used to determine the effect of CEAA on anti- and pro-apoptotic proteins (Bcl-2 and Bax, respectively). The 4T1 cell-challenged mice were used for in vivo assay.
		                        		
		                        			RESULTS:
		                        			Using ultra-high-performance liquid chromatography-mass spectrometry analysis, angelicin, a constituent of the roots and leaves of A. archangelica, was found to be the major constituent of the CEAA evaluated in this study (73 µg/mL). The CEAA was cytotoxic for both breast cancer cell lines studied but not for human fibroblasts. Treatment of 4T1 cells with the CEAA increased Bax protein levels accompanied by decreased Bcl-2 expression, in the presence of cleaved caspase-3 and cytosolic calcium mobilization, suggesting mitochondrial involvement in breast cancer cell death induced by the CEAA in this cell line. No changes on the Bcl-2/Bax ratio were observed in CEAA-treated MCF7 cells. Gavage administration of the CEAA (500 mg/kg) to 4T1 cell-challenged mice significantly decreased tumor growth when compared with untreated animals.
		                        		
		                        			CONCLUSION
		                        			Altogether, our data show the antitumor potential of the CEAA against breast cancer cells in vitro and in vivo. Further research is necessary to better elucidate the pharmacological application of the CEAA in breast cancer therapy.
		                        		
		                        		
		                        		
		                        	
3.Biomarker detection in urinary proteome of prostate cancer by nanoflow LC-MS/MS.
Autus-Geniston Leonora V ; Garcia Carlos P ; Ramos John Donnie A ; Tuazon Alexander O ; Estanislao Virgilio C
Acta Medica Philippina 2013;47(2):13-21
		                        		
		                        			
		                        			<p style="text-align: justify;">INTRODUCTION: Urinary proteomics provides a wealth of information in the identification of protein markers associated with various diseases such as in carcinoma. With the increasing incidence of prostate cancer and the lack of sensitivity and specificity of prostate specific antigen, the simultaneous identification of an alternative protein biomarker through urinary proteomics is encouraging. Urine, which has similar proteins with serum, makes it an ideal alternative biofluid wherein the collection is easy and non-invasive.
METHODS: Urinary proteins were separated by gradient SDS-PAGE followed by in-gel digestion and organic/buffer peptide extraction. The protein biomarkers in prostate cancer patients and control subjects were identified via LC-MS/MS and submitted to Protein Prospector where the peptide fragmentation of sequence was analyzed and compared with the SwissProt database.
RESULTS: A panel of three protein biomarkers for the early detection of prostate cancer were identified: transthyretin, hemoglobin subunit alpha and hemoglobin sububit beta. The presence of these three biomarkers is associated with high Gleason scores and TNM stages but not with PSA level. Uromodulin and mannan binding lectin serine protease cancer from BPH. The study also revealed the divergence of the urinary proteome of the cancer patients from the urinary proteome of the control with BPH suggesting the fundamental differences in benign and malignant growth of the prostate epithelial cells. Another highlight of the study was the identification of oxidation of pro63 of transthyretin in patient 3. The proposed role of the post translational modification in pro63 of transthyretinin in the mechanism of prostate carcinogenesis remains to be defined and warrants further study.
CONCLUSION: Our study was able to establish the homology of urine proteome among the controls and its divergence from the patients afflicted with prostate cancer by simultaneously comparing their urine proteomes leading to the identification of a distinct panel of biomarkers, namely, transthyretin, hemoglobin subunit alpha and hemoglobin subunit beta. Uromodulin and mannan binding lectin serine protease 2 are the additional biomarkers that can distinguish prostate cancer from BPH. Due to limitations in the number of controls and patients, only preliminary findings and their significance were shown. These findings need to be confirmed in future investigations using larger sample size for both the controls and the patients.p>
		                        		
		                        		
		                        		
		                        			Human
		                        			;
		                        		
		                        			 Male
		                        			;
		                        		
		                        			 Prostate-specific Antigen
		                        			;
		                        		
		                        			 Proteome
		                        			;
		                        		
		                        			 Proteomics
		                        			;
		                        		
		                        			 Prealbumin
		                        			;
		                        		
		                        			 Uromodulin
		                        			;
		                        		
		                        			 Serine Proteases
		                        			;
		                        		
		                        			 Mannose-binding Lectin
		                        			;
		                        		
		                        			 Prostatic Neoplasms
		                        			;
		                        		
		                        			 Carcinogenesis
		                        			;
		                        		
		                        			 Peptides
		                        			;
		                        		
		                        			 Hemoglobins
		                        			;
		                        		
		                        			 Epithelial Cells
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail